title: Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease.
authors.affiliation: Center for Systemic Manifestations of Hepatitis Viruses (MaSVE), Department of Internal Medicine, University of Florence, Florence, Italy.
authors.forename: Antonio
authors.initials: A
authors.lastname: Petrarca
authors.forename: Luigi
authors.initials: L
authors.lastname: Rigacci
authors.forename: Patrizio
authors.initials: P
authors.lastname: Caini
authors.forename: Stefano
authors.initials: S
authors.lastname: Colagrande
authors.forename: Paolo
authors.initials: P
authors.lastname: Romagnoli
authors.forename: Francesco
authors.initials: F
authors.lastname: Vizzutti
authors.forename: Umberto
authors.initials: U
authors.lastname: Arena
authors.forename: Carlo
authors.initials: C
authors.lastname: Giannini
authors.forename: Monica
authors.initials: M
authors.lastname: Monti
authors.forename: Paolo
authors.initials: P
authors.lastname: Montalto
authors.forename: Marco
authors.initials: M
authors.lastname: Matucci-Cerinic
authors.forename: Alberto
authors.initials: A
authors.lastname: Bosi
authors.forename: Giacomo
authors.initials: G
authors.lastname: Laffi
authors.forename: Anna Linda
authors.initials: AL
authors.lastname: Zignego
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000276:immunology; D003449:Cryoglobulinemia / Q000188:drug therapy* / Q000209:etiology* / Q000276:immunology; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D012157:Mononuclear Phagocyte System / Q000473:pathology; D011446:Prospective Studies; D012367:RNA, Viral / Q000097:blood; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D012367:RNA, Viral; D000069283:Rituximab